Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
Zentalis Pharmaceuticals, Inc. (ZNTL) had Receiveable Turnover of 13.48 for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$67.42M |
|
$-165.84M |
|
-- |
|
$67.42M |
|
$258.62M |
|
$-191.19M |
|
$25.50M |
|
$-165.69M |
|
$-165.69M |
|
$-165.87M |
|
$-165.87M |
|
$-165.87M |
|
$-165.87M |
|
$-191.19M |
|
$-194.17M |
|
71.08M |
|
71.08M |
|
$-2.33 |
|
$-2.33 |
|
| Balance Sheet Financials | |
$386.07M |
|
$4.70M |
|
$44.27M |
|
$430.34M |
|
$52.73M |
|
-- |
|
$40.43M |
|
$93.15M |
|
$337.19M |
|
$337.19M |
|
$337.19M |
|
71.28M |
|
| Cash Flow Statement Financials | |
$-170.86M |
|
$176.56M |
|
$0.11M |
|
$30.72M |
|
$36.53M |
|
$5.81M |
|
$67.27M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.32 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-283.57% |
|
-283.57% |
|
-287.98% |
|
-245.74% |
|
-245.96% |
|
$-171.02M |
|
-- |
|
-- |
|
-- |
|
0.16 |
|
-- |
|
|
Receiveable Turnover |
13.48 |
27.07 |
|
-49.19% |
|
-49.19% |
|
-38.54% |
|
-49.19% |
|
$4.73 |
|
$-2.41 |
|
$-2.40 |
|